Search results: Sage Journals

Open accessResearch articleFirst published 2023

Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer and thyroid cancer,and RET -mutant medullary thyroid cancer in the phase II LIBRETTO-321 trial

Shun Lu, Xiangqian Zheng, Yuping Sun [...]

Therapeutic Advances in Medical Oncology

Restricted accessReview articleFirst published September, 1963

Verdi Librettos

Music Educators Journal

Open accessResearch articleFirst published July, 2025

Guignol parodies Shakespeare: A case study of Guignol et Juliette and Hamlet by Pierre Rousset

Yanna Kor

Cahiers Élisabéthains: A Journal of English Renaissance Studies

Restricted accessReview articleFirst published February, 1963

A Treasury of Opera Librettos

Music Educators Journal

Open accessResearch articleFirst published 2022

Efficacy and safety of selpercatinib in Chinese patients with advanced RET -altered thyroid cancers: results from the phase II LIBRETTO-321 study

Xiangqian Zheng, Qinghai Ji, Yuping Sun [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published July, 2000

The Music or the Words? Or How Important is the Libretto for an Opera's Aesthetic Success?

Dean Keith Simonton

Empirical Studies of the Arts

Restricted accessResearch articleFirst published June, 1973

All Happy Endings: Libretti of the Late Seicento

Beatrice Corrigan

Forum Italicum: A Journal of Italian Studies

Open accessResearch articleFirst published October, 2025

Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET -Mutant Medullary Thyroid Cancer

Rossella Elisei, Lori J. Wirth, Jaume Capdevila [...]

Thyroid®

Open accessResearch articleFirst published 2022

Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321)

Shun Lu, Ying Cheng, Dingzhi Huang [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2025

Selpercatinib in Chinese patients with RET -fusion-positive non-small-cell lung cancer: updated efficacy and safety analysis from the LIBRETTO-321 phase II trial

Shun Lu, Ying Cheng, Dingzhi Huang [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2023

Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer and thyroid cancer,and RET -mutant medullary thyroid cancer in the phase II LIBRETTO-321 trial

Shun Lu, Xiangqian Zheng, Yuping Sun [...]

Therapeutic Advances in Medical Oncology

Restricted accessReview articleFirst published September, 1963

Verdi Librettos

Music Educators Journal

Open accessResearch articleFirst published July, 2025

Guignol parodies Shakespeare: A case study of Guignol et Juliette and Hamlet by Pierre Rousset

Yanna Kor

Cahiers Élisabéthains: A Journal of English Renaissance Studies

Restricted accessReview articleFirst published February, 1963

A Treasury of Opera Librettos

Music Educators Journal

Open accessResearch articleFirst published 2022

Efficacy and safety of selpercatinib in Chinese patients with advanced RET -altered thyroid cancers: results from the phase II LIBRETTO-321 study

Xiangqian Zheng, Qinghai Ji, Yuping Sun [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published July, 2000

The Music or the Words? Or How Important is the Libretto for an Opera's Aesthetic Success?

Dean Keith Simonton

Empirical Studies of the Arts

Restricted accessResearch articleFirst published June, 1973

All Happy Endings: Libretti of the Late Seicento

Beatrice Corrigan

Forum Italicum: A Journal of Italian Studies

Open accessResearch articleFirst published October, 2025

Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET -Mutant Medullary Thyroid Cancer

Rossella Elisei, Lori J. Wirth, Jaume Capdevila [...]

Thyroid®

Open accessResearch articleFirst published 2022

Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321)

Shun Lu, Ying Cheng, Dingzhi Huang [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2025

Selpercatinib in Chinese patients with RET -fusion-positive non-small-cell lung cancer: updated efficacy and safety analysis from the LIBRETTO-321 phase II trial

Shun Lu, Ying Cheng, Dingzhi Huang [...]

Therapeutic Advances in Medical Oncology